{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T03:51:22Z","timestamp":1775879482141,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T00:00:00Z","timestamp":1536969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40792-018-0512-6","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T02:51:34Z","timestamp":1537066294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Long-term survival of a patient with recurrent gallbladder carcinoma, treated with chemotherapy, immunotherapy, and surgery: a case report"],"prefix":"10.1186","volume":"4","author":[{"given":"Makoto","family":"Kawamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Koya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Takami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Saitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineo","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideya","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,15]]},"reference":[{"key":"512_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10120-015-0575-z","volume":"19","author":"K Yoshida","year":"2016","unstructured":"Yoshida K, Yamaguchi K, Okumura N, Tanahashi T, Kodera Y. Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification. Gastric Cancer. 2016;19:329\u201338.","journal-title":"Gastric Cancer"},{"key":"512_CR2","first-page":"2505","volume":"31","author":"T Morisaki","year":"2011","unstructured":"Morisaki T, Onishi H, Koya N, Kiyota A, Tanaka H, Umebayashi M, et al. Combinatorial cytotoxicity of gemcitabine and cytokine-activated killer cells in hepatocellular carcinoma via the NKG2D-MICA\/B system. Anticancer Res. 2011;31:2505\u2013250.","journal-title":"Anticancer Res"},{"key":"512_CR3","first-page":"4529","volume":"34","author":"T Morisaki","year":"2014","unstructured":"Morisaki T, Hirano T, Koya N, Kiyota A, Tanaka H, Umebayashi M, et al. NKG2D-directed cytokine-activated killer lymphocyte therapy combined with gemcitabine for patients with chemoresistant metastatic solid tumors. Anticancer Res. 2014;34:4529\u201338.","journal-title":"Anticancer Res"},{"key":"512_CR4","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2618::AID-CNCR29>3.0.CO;2-H","volume":"83","author":"JH Donohue","year":"1998","unstructured":"Donohue JH, Stewart AK, Menck HR. The national cancer data base report on carcinoma of the gallbladder, 1989\u20131995. Cancer. 1998;83:2618\u201328.","journal-title":"Cancer"},{"key":"512_CR5","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/sj.bjc.6603648","volume":"96","author":"F Eckel","year":"2007","unstructured":"Eckel F, Schmid RM. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer. 2007;96:896\u2013902.","journal-title":"Br J Cancer"},{"key":"512_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jso.21141","volume":"98","author":"A Duffy","year":"2008","unstructured":"Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, et al. Gallbladder cancer (GBC): 10-year experience at memorial Sloan-Kettering cancer centre (MSKCC). J Surg Oncol. 2008;98:485\u20139.","journal-title":"J Surg Oncol"},{"key":"512_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1272\/jnms.73.136","volume":"73","author":"T Shimizu","year":"2006","unstructured":"Shimizu T, Arima Y, Yokomuro S, Yoshida H, Mamada Y, Nomura T, et al. Incidental gallbladder cancer diagnosed during and after laparoscopic cholecystectomy. J Nippon Med Sch. 2006;73:136\u201340.","journal-title":"J Nippon Med Sch"},{"key":"512_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00534-006-1187-0","volume":"14","author":"H Nishio","year":"2007","unstructured":"Nishio H, Nagino M, Ebata T, Yokoyama Y, Igami T, Nimura Y. Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications? J Hepato-Biliary-Pancreat Surg. 2007;14:351\u20137.","journal-title":"J Hepato-Biliary-Pancreat Surg"},{"key":"512_CR9","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/sj.bjc.6601736","volume":"90","author":"DC Doval","year":"2004","unstructured":"Doval DC, Sekhon JS, Gupta SK, Fuloria J, Shukla VK, Gupta S, et al. A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer. 2004;90:1516\u201320.","journal-title":"Br J Cancer"},{"key":"512_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/annonc\/mdi046","volume":"16","author":"S Thongprasert","year":"2005","unstructured":"Thongprasert S, Napapan S, Charoentum C, Moonprakan S. Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol. 2005;16:279\u201381.","journal-title":"Ann Oncol"},{"key":"512_CR11","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/cncr.21741","volume":"106","author":"ST Kim","year":"2006","unstructured":"Kim ST, Park JO, Lee J, Lee KT, Lee JK, Choi SH, et al. A phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Cancer. 2006;106:1339\u201346.","journal-title":"Cancer"},{"key":"512_CR12","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1440-1746.2006.04230.x","volume":"21","author":"BK Park","year":"2006","unstructured":"Park BK, Kim YJ, Park JY, Bang S, Park SW, Chung JB, et al. Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. J Gastroenterol Hepatol. 2006;21:999\u20131003.","journal-title":"J Gastroenterol Hepatol"},{"key":"512_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00534-011-0437-y","volume":"19","author":"K Shimizu","year":"2012","unstructured":"Shimizu K, Kotera Y, Aruga A, Takeshita N, Terasaki K, Yamamoto M. Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholonagiocarcinoma. J Hepatobiliary Pancreat Sci. 2012;19:171\u20138.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"512_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00262-014-1613-0","volume":"64","author":"H Kimura","year":"2015","unstructured":"Kimura H, Matsui Y, Ishikawa A, Nakajima T, Yoshino M, Sakairi Y. Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer. Cancer Immunol Immunother. 2015;64:51\u20139.","journal-title":"Cancer Immunol Immunother"},{"key":"512_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00262-012-1311-8","volume":"62","author":"L Yang","year":"2013","unstructured":"Yang L, Ren B, Li H, Yu J, Cao S, Hao X, Ren X. Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small cell lung cancer patients. Cancer Immunol Immunother. 2013;62:65\u201373.","journal-title":"Cancer Immunol Immunother"},{"key":"512_CR16","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/ijc.30475","volume":"140","author":"H Nagase","year":"2017","unstructured":"Nagase H, Takeoka T, Urakawa S, Morimoto-Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686\u201395.","journal-title":"Int J Cancer"},{"key":"512_CR17","first-page":"2241","volume":"32","author":"T Morisaki","year":"2012","unstructured":"Morisaki T, Onishi H, Katano M. Cancer immunotherapy using NKG2D and DNAM-1 systems. Anticancer Res. 2012;32:2241\u20137.","journal-title":"Anticancer Res"},{"key":"512_CR18","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1038\/onc.2008.272","volume":"27","author":"N Nausch","year":"2008","unstructured":"Nausch N, Cerwenka A. NKG2D ligands in tumor immunity. Oncogene. 2008;27:5944\u201358.","journal-title":"Oncogene"},{"key":"512_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00262-008-0635-x","volume":"58","author":"C Maccalli","year":"2009","unstructured":"Maccalli C, Scaramuzza S, Parmiani G. TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors. Cancer Immunol Immunother. 2009;58:801\u20138.","journal-title":"Cancer Immunol Immunother"},{"key":"512_CR20","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1200\/JCO.2006.07.1100","volume":"24","author":"A Meckensen","year":"2006","unstructured":"Meckensen A, Meidenbauer N, Vogl S, Laumer M, Berger J, Andreesen R. Phase I study of adoptive T-cell therapy using antigen specific CD8+ T cells for the treatment of patients with metastatic melanoma. J Clin Oncol. 2006;24:5060\u20138.","journal-title":"J Clin Oncol"},{"key":"512_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/14653249.2011.610303","volume":"14","author":"D Montagna","year":"2012","unstructured":"Montagna D, Turin I, Schiavo R, Montini E, Zaffaroni N, Villa R, et al. Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor. Cytotherapy. 2012;14:80\u201390.","journal-title":"Cytotherapy"},{"key":"512_CR22","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1056\/NEJMoa0800251","volume":"358","author":"NN Hunder","year":"2008","unstructured":"Hunder NN, Wallen H, Cao J, Hendricks DW, Reilly JZ, Rondmyre R, et al. Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. New Engl J Med. 2008;358:2698\u2013703.","journal-title":"New Engl J Med"},{"key":"512_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jso.22055","volume":"105","author":"L Xiong","year":"2012","unstructured":"Xiong L, Yang Z, Yang L, Liu J, Miao X. Expressive levels of MUC-1 and MUC-5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder. J Sur Oncol. 2012;105:97\u2013103.","journal-title":"J Sur Oncol"},{"key":"512_CR24","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s11605-013-2286-2","volume":"9","author":"M Kobayashi","year":"2013","unstructured":"Kobayashi M, Sakabe T, Abe H, Tanii M, Takahashi H, Chiba A, et al. Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer. J Gastrointest Surg. 2013;9:1609\u201317.","journal-title":"J Gastrointest Surg"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-018-0512-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40792-018-0512-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-018-0512-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T23:05:26Z","timestamp":1568502326000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-018-0512-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,15]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["512"],"URL":"https:\/\/doi.org\/10.1186\/s40792-018-0512-6","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,15]]},"assertion":[{"value":"21 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"115"}}